Seda Pharmaceutical Development Services’ Post

Missed our Thought Leadership Panel Discussion on the importance of High-Complexity Flow Cytometry in Clinical Trials? No problem – it's now available to watch on-demand! In partnership with Bioanalysis Zone, Champions hosted an insightful discussion with clinical flow cytometry experts: Steven Eck, PhD (AstraZeneca), Jonni S Moore, PhD (University of Pennsylvania), and Brandon Walling, PhD (Champions Oncology). Together they explored the key challenges and opportunities of integrating flow cytometry endpoints in clinical trials. 🎥 Watch now and get expert insights: https://hubs.ly/Q02-Q6tz0 #FlowCytometry #ClinicalSpecialtyTesting #ClinicalTrials

Thank you for meeting with us at PMLS Precision Oncology & Diagnostics 2024 in Chicago! Our Chief Precision Medicine Officer, Susanne Munksted, delivered a talk on “Are We Closer to Fulfilling the Patient Promise of Precision Oncology?” This presentation expanded on insights from Diaceutics’ globally recognized Practice Gaps report, providing an update on how these practice gaps have evolved since 2022. Susanne also highlighted actionable steps the industry can take to address operational, economic, and policy challenges in precision medicine, drawing from the five key recommendations outlined by The Health and Economic Forum in the newly released Recommendations paper. For more information, and to download the recommendations paper, click the link below: https://lnkd.in/e7FnGF49 #PrecisionMedicine #BetterTestingBetterTreatement

👀🎬 A look back on the first edition of #THRPTX. Few days ago, we hosted the inaugural Therapeutics Innovation Summit (THRPTX) at our R&D Institute at Paris-Saclay. This groundbreaking event brought together world-renowned scientists, researchers, and industry leaders to explore the frontiers of medical innovation, with a focus on oncology. 🔎 From AI-driven drug discovery to cutting-edge immunotherapies, the discussions illuminated pathways to transform patient care. Prof. William G. Kaelin, 2019 Nobel Laureate in Medicine, set the tone with his inspiring keynote on cellular adaptation to oxygen availability. 👉 The summit exemplified our commitment to open innovation and collaborative research. By fostering dialogue between diverse stakeholders, we aim to accelerate therapeutic progress and address unmet medical needs. 🙏 We're immensely grateful to all participants for their invaluable contributions. The insights gained will fuel our ongoing efforts to develop innovative solutions for patients facing cancer. Read more 👉 https://swll.to/xDshrVA #WeAreServier #MovedByYou #innovation #health

We're really looking forward to the Precision Oncology & Diagnostics summit 2024 next week in Chicago, I'm excited to have the opportunity to showcase the latest version of ARC360 v2.1 our regulatory intelligence platform. If you would like to meet with Seamus Kearney and I, please do send us a meeting request or send me a message, looking forward to catching up with friends, colleagues & peers within the Precision Medicine industry.#ARC360 #Oncology #Precision #Medicine #IVD #CDx #Global #Regulatory Reflecting recently on ARC360, our CEO Seamus Kearney said "ARC360 is revolutionising the way organisations access regulatory intelligence and tailor study specific information and guidance based on how they are using in vitro diagnostics to select and manage patients in IND trials. A truly unique offering, powered by the latest technologies and supported by a team of regulatory, quality, and clinical operations experts, ARC360 is set to accelerate typical timelines for initiating complex clinical trials."

ARC Regulatory is attending the Precision Oncology & Diagnostics Summit taking place on the 15th and 16th of October in Chicago, IL, US. Our team members Darren Ross, BD Manager ARC360 and Seamus Kearney, CEO will be there, and looking forward to attending as many sessions and meeting as many precision medicine colleagues as they can over the conference days. Why not schedule a meeting to discuss our IVD study Sponsor Delegation model in translational medicine, and how #ARC360 is revolutionising study set up for your peers in precision medicine clinical development? https://bit.ly/47RjwGw #ARCRegulatory #Oncology #PrecisionMedicine #IVD #CDx #SponsorDelegation #ARC360

Discover how leveraging real world data can illuminate the path to successful biomarker discovery and targeted drug development. Register at https://buff.ly/4f1b76a Featuring: - Keith Flaherty, MD, Director of Clinical Research at the Massachusetts General Hospital Cancer Centre and Professor of Medicine at Harvard Medical School - Siraj A., MD, Global Vice President, Translation Medicine, Lunit - Saurabh Sewak, PhD, VP, Corporate and Business Development, Foghorn Therapeutics - Eleonora Iob, PhD, Research Manager, PHARMO Institute, part of Lumanity - Dennis Chang, PhD, SVP, Strategy Consulting, Lumanity Can't make it? Register to get the recording. #PrecisionOncology #RealWorldData #DrugDevelopment #Oncology #RWE #RealWorldEvidence

Join Regina Hargrove at #SROA2024 today at 3:45pm for "Hypofractionation: The Impacts of Clinical Advancements". This presentation will discuss the interplay between reimbursement dynamics, technological innovations, and clinical practice. This presentation aims to provide valuable insights for radiation oncology administrators grappling with the complexities of hypofractionation. Questions for our experts? Connect with them here or contact us at [email protected].

𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 𝐝𝐞𝐬𝐢𝐠𝐧𝐬- that was the topic of a talk I was invited to present at the 16th Clinical Trials Strategic Summit (#CTSS) in Munich recently. While preparing my presentation, I realized how these new approaches are actually not so new anymore. Interestingly, without even realising, I have been involved in, supported, led, or simply observed many of these innovations, my first encounter being over a decade ago with the I-SPY2 trials (https://lnkd.in/deVR27jg) Innovations like umbrella, basket, telescope, and platform trials seem to be more common than you think, and I have seen many proposals recently by academic collaborative groups for adaptive platforms that allow for adding new drugs under a master protocol. Interested to hear from my network about your personal experiences with innovative trial designs. 1. What’s the 𝐦𝐨𝐬𝐭 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐭𝐫𝐢𝐚𝐥 𝐝𝐞𝐬𝐢𝐠𝐧 you have led, been involved in or simply witnessed? 2. Any insights from those who recently attended #𝐀𝐒𝐂𝐎?  3. Have there been any successful examples of 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲-𝐬𝐩𝐨𝐧𝐬𝐨𝐫𝐞𝐝 𝐩𝐫𝐚𝐠𝐦𝐚𝐭𝐢𝐜 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 ? #Oncology #ClinicalTrials #Innovation

Our blood travels through a circulatory network of arteries, veins and capillaries that is about 100,000 kilometers long. And it goes around thanks to our hearts beating about 100,000 times per day (some interesting symmetry). I won’t speculate how many times “blood actually goes around the body” per day, but what seems clear is that our hearts pump more than 1000 x of our total volume of blood per day. As it circulates through this extensive network, blood is enriched with information from every tissue and organ, information that can inform on our health and disease. And every company below👇🏾 is developing a technology that is pushing the boundaries of what can be learned from taking a small sample of blood, technologies that could radically impact how disease is detected and treated 🩸 Looking forward to the conversation, DeciBio #liquidbiopsy #healthcare

Co-authors Diana Brixner, BPharm, PhD, FAMCP; NOREEN MATTHEWS; Terry Richardson, PharmD, BCACP; Daryl Pritchard, PhD; John Fox, MD, MHA; Scott Ramsey, PhD, MD are pleased to share the accepted poster “Optimizing The Use of Oncology Biomarker Testing Using Health Plan Best Practices and Quality Measures” at #AMCPNexus 2024. To learn more, please visit poster # C23 Poster abstract available in the latest supplement of JMCP (page S21): https://lnkd.in/ezkNUWFZ #precisiononcology #AMCPmarketinsights